Overview
Naoko Morishita practices practicing medicine in Osaka, Japan.
Ms. Morishita is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Epithelial-Myoepithelial Carcinoma, and Endoscopy.
She is actively involved in clinical research, co-authoring 58 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Naoko Morishita
Is Naoko Morishita a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Naoko Morishita is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Naoko Morishita participate in research or clinical trials?
Yes. Naoko Morishita has published 58 articles and abstracts on conditions like Lung Cancer. You can view a list of Naoko Morishita's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- EGFR Positive Lung CancerMs. Morishita isAdvanced. Learn about EGFR Positive Lung Cancer.
- Lung CancerMs. Morishita isAdvanced. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Morishita isAdvanced. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Experienced
- Acute Interstitial PneumoniaMs. Morishita isExperienced. Learn about Acute Interstitial Pneumonia.
- Bone TumorMs. Morishita isExperienced. Learn about Bone Tumor.
- DiarrheaMs. Morishita isExperienced. Learn about Diarrhea.
- EmpyemaMs. Morishita isExperienced. Learn about Empyema.
- EndoscopyMs. Morishita isExperienced. Learn about Endoscopy.
- Epithelial-Myoepithelial CarcinomaMs. Morishita isExperienced. Learn about Epithelial-Myoepithelial Carcinoma.
- Follicular Thyroid CancerMs. Morishita isExperienced. Learn about Follicular Thyroid Cancer.
- Hypersensitivity PneumonitisMs. Morishita isExperienced. Learn about Hypersensitivity Pneumonitis.
- Interstitial Lung DiseaseMs. Morishita isExperienced. Learn about Interstitial Lung Disease.
- Lung AdenocarcinomaMs. Morishita isExperienced. Learn about Lung Adenocarcinoma.
- MesotheliomaMs. Morishita isExperienced. Learn about Mesothelioma.
- ParonychiaMs. Morishita isExperienced. Learn about Paronychia.
- Pleural EffusionMs. Morishita isExperienced. Learn about Pleural Effusion.
- Pseudomembranous ColitisMs. Morishita isExperienced. Learn about Pseudomembranous Colitis.
- Salivary Gland TumorsMs. Morishita isExperienced. Learn about Salivary Gland Tumors.
- Small Cell Lung Cancer (SCLC)Ms. Morishita isExperienced. Learn about Small Cell Lung Cancer (SCLC).